Literature DB >> 8144671

Evidence that an approximately 50-kDa mammalian plasma membrane protein with receptor-like properties mediates the amphiphilicity of specifically bound Clostridium perfringens enterotoxin.

E U Wieckowski1, A P Wnek, B A McClane.   

Abstract

Previous studies suggest that Clostridium perfringens enterotoxin (CPE) inserts into mammalian membranes. Using Triton X-114 phase separation analysis and charge-shift electrophoresis, this study demonstrates that CPE exhibits the amphiphilicity required for membrane insertion, but this behavior develops only after exposure of CPE to membranes. This effect does not require proteolytic or covalent CPE modifications or formation of a previously reported 160-kDa CPE-containing complex. A novel 90-kDa CPE-containing complex with amphiphilic properties was detected in intestinal brush-border membranes and in CPE-sensitive, but not CPE-insensitive, cell lines using nondenaturing Triton X-100 electrophoresis. Immunoprecipitation analysis suggested that the 90-kDa complex is composed of CPE and a 45-50-kDa membrane protein. Since the 90-kDa complex is formed only in cells that bind and respond to CPE, these results are consistent with the 45-50-kDa protein mediating CPE amphiphilicity and serving as a functional CPE receptor. A four-step model for CPE action is proposed. 1) CPE binds to the 45-50-kDa protein to form a 90-kDa complex. 2) The 90-kDa complex undergoes some physical change corresponding to insertion or a conformational change. 3) The 90-kDa complex and a 70-kDa membrane protein interact to form a 160-kDa complex. 4) Formation of the 160-kDa complex leads to permeability alterations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144671

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation.

Authors:  J Berkes; V K Viswanathan; S D Savkovic; G Hecht
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

2.  Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin.

Authors:  Ganes Chakrabarti; Xin Zhou; Bruce A McClane
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 3.  Comparative pathogenesis of enteric clostridial infections in humans and animals.

Authors:  Francisco A Uzal; Mauricio A Navarro; Jihong Li; John C Freedman; Archana Shrestha; Bruce A McClane
Journal:  Anaerobe       Date:  2018-06-05       Impact factor: 3.331

4.  Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity.

Authors:  James G Smedley; Juliann Saputo; Jacquelyn C Parker; Mariano E Fernandez-Miyakawa; Susan L Robertson; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

5.  Evidence that membrane rafts are not required for the action of Clostridium perfringens enterotoxin.

Authors:  Justin A Caserta; Martha L Hale; Michel R Popoff; Bradley G Stiles; Bruce A McClane
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

6.  Deletion analysis of the Clostridium perfringens enterotoxin.

Authors:  J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

7.  Clostridium perfringens enterotoxin damages the human intestine in vitro.

Authors:  M E Fernández Miyakawa; V Pistone Creydt; F A Uzal; B A McClane; C Ibarra
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

8.  Potential Therapeutic Effects of Mepacrine against Clostridium perfringens Enterotoxin in a Mouse Model of Enterotoxemia.

Authors:  Mauricio A Navarro; Archana Shrestha; John C Freedman; Juliann Beingesser; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

9.  Characterization of membrane-associated Clostridium perfringens enterotoxin following pronase treatment.

Authors:  E U Wieckowski; J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Evidence that a region(s) of the Clostridium perfringens enterotoxin molecule remains exposed on the external surface of the mammalian plasma membrane when the toxin is sequestered in small or large complexes.

Authors:  J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.